mitomycin has been researched along with fr 66973 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manda, T; Masuda, K; Matsumoto, S; Mori, J; Nakamura, T; Oku, T; Shimomura, K | 1 |
| Hattori, Y; Hirai, O; Mine, Y; Miyamae, Y; Miyamoto, A; Takashima, M; Zaizen, K | 1 |
| Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Miyayasu, K; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S | 1 |
3 other study(ies) available for mitomycin and fr 66973
| Article | Year |
|---|---|
Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cytarabine; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mitomycin; Mitomycins; Mitosis; Oxazines; Time Factors; Vinblastine | 1989 |
Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Mitomycin; Mutagenicity Tests; Mutation; Oxazines; Salmonella typhimurium | 1994 |
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1998 |